The DOI matches its Crossref record; 276 of the 276 references it cites were found in a registry or an index.
Sphingolipids, Insulin Resistance, and Metabolic Disease: New Insights from in Vivo Manipulation of Sphingolipid Metabolism
Open accessAbstract
Obesity and dyslipidemia are risk factors for metabolic disorders including diabetes and cardiovascular disease.Sphingolipids such as ceramide and glucosylceramides, while being a relatively minor component of the lipid milieu in most tissues, may be among the most pathogenic lipids in the onset of the sequelae associated with excess adiposity.Circulating factors associated with obesity (e.g., saturated fatty acids, inflammatory cytokines) selectively induce enzymes that promote sphingolipid synthesis, and lipidomic profiling reveals relationships between tissue sphingolipid levels and certain metabolic diseases.Moreover, studies in cultured cells and isolated tissues implicate sphingolipids in certain cellular events associated with diabetes and cardiovascular disease, including insulin resistance, pancreatic -cell failure, cardiomyopathy, and vascular dysfunction.However, definitive evidence that sphingolipids contribute to insulin resistance, diabetes, and atherosclerosis has come only recently, as researchers have found that pharmacological inhibition or genetic ablation of enzymes controlling sphingolipid synthesis in rodents ameliorates each of these conditions.Herein we will review the role of ceramide and other sphingolipid metabolites in insulin resistance, -cell failure, cardiomyopathy, and vascular dysfunction, focusing on these in vivo studies that identify enzymes controlling sphingolipid metabolism as therapeutic targets for combating metabolic disease.(Endocrine Reviews 29: 381-402, 2008) I. Introduction II.Regulation of Sphingolipid Synthesis and Metabolism: Effect of Obesity A. Sphingolipids in the diet B. Regulation of sphingolipid synthesis and metabolism during obesity C. Quantification of sphingolipid levels during obesity III.Sphingolipids in Atherosclerosis A. Modulation of sphingolipid levels prevents plaque formation in ApoE-deficient mice B. Mechanism by which sphingolipids promote atherosclerosis and thrombosis IV.Sphingolipids in Insulin Resistance A. Modulating sphingolipid levels impacts insulin sensitivity in vivo B. Mechanism by which sphingolipids antagonize insulin action V. Sphingolipids in Pancreatic -Cell Failure A. Modulating sphingolipid levels impacts the -cell in rodent models of diabetes B. Mechanism of ceramide-mediated -cell failure C. Mechanism of glucoslyceramide-mediated -cell failure D. S1P as a regulator of -cell growth and survival VI.Sphingolipids in Cardiomyopathy A. Modulating sphingolipid levels ameliorates cardiac dysfunction in a rodent model of lipotoxic cardiomyopathy B. Mechanism by which ceramides promote cardiomyocyte dysfunction and apoptosis VII.Conclusions and Considerations
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–276 of 276
Craddock, B. L., Orchiston, E. A., Hinton, H. J., & Welham, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10633 · Cited by 100
Metabolic Mechanisms of Failure of Intraportally Transplanted Pancreatic β-Cells in Rats
Lee, Y., Ravazzola, M., Park, B., Bashmakov, Y. K., Orci, L., & Unger, R. H. (2007) · Diabetes · doi:10.2337/db07-0460 · Cited by 100
Metabolic syndrome: what is it and what are the implications?
Shaw, D. I., Hall, W. L., & Williams, C. M. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2005442 · Cited by 98
Störz, P., Döppler, H. R., Wernig, A., Pfizenmaier, K., & Müller, G. I. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00809.x · Cited by 95
Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice
Park, T., Panek, R. L., Rekhter, M. D., Mueller, S. B., Rosebury, W. S., Robertson, A. W., Hanselman, J. C., Kindt, E. K., Homan, R., & Karathanasis, S. K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.029 · Cited by 95
Brain gangliosides: Functional ligands for myelin stability and the control of nerve regeneration
Vyas, A. A., & Schnaar, R. L. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01308-6 · Cited by 95
Watt, M. J., Hevener, A. L., Lancaster, G. I., & Febbraio, M. A. (2006) · Endocrinology · doi:10.1210/en.2005-1074 · Cited by 92
Enlargement and Contracture of C2-Ceramide Channels
Siskind, L. J., Davoody, A., Lewin, N., Marshall, S., & Colombini, M. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74588-3 · Cited by 92
Apoptosis and Heart Failure: Mechanisms and Therapeutic Implications
Chen, Q. M., & Tu, V. C. (2002) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200202010-00006 · Cited by 90
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 88
Dexamethasone down-regulation of insulin receptor substrate-1 in 3T3-L1 adipocytes.
Turnbow, M., Keller, S. R., Rice, K. M., & Garner, C. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41975-2 · Cited by 87
Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption
Linn, S. C., Kim, H. S., Keane, E. M., Andras, L. M., Wang, E., & Merrill, A. H. (2001) · Biochemical Society Transactions · doi:10.1042/0300-5127:0290831 · Cited by 87
Lightle, S. A., Tosheva, R., Lee, A. S., Queen-Baker, J., Boyanovsky, B. B., Shedlofsky, S., & Nikolova‐Karakashian, M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.031 · Cited by 87
Exercise and training effects on ceramide metabolism in human skeletal muscle
Helge, J. W., Dobrzyń, A., Saltin, B., & Górski, J. (2003) · Experimental Physiology · doi:10.1113/expphysiol.2003.002605 · Cited by 86
Hyperleptinemia: Protecting the Heart From Lipid Overload
Unger, R. H. (2005) · Hypertension · doi:10.1161/01.hyp.0000165683.09053.02 · Cited by 85
Ceramide-1-phosphate: The "missing" link in eicosanoid biosynthesis and inflammation
Lamour, N. F., & Chalfant, C. E. (2005) · Molecular Interventions · doi:10.1124/mi.5.6.8 · Cited by 84
Tomlinson, J., & Stewart, P. M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0023 · Cited by 82
Zinda, M. J., Vlahos, C. J., & Lai, M. T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4248 · Cited by 80
Increased expression of 11β‐hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes
Abdallah, B. M., Beck‐Nielsen, H., & Gaster, M. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01552.x · Cited by 80
Sphingosine Forms Channels in Membranes That Differ Greatly from Those Formed by Ceramide
Siskind, L. J., Fluss, S., Bui, M., & Colombini, M. (2005) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-005-6632-2 · Cited by 80
Insulin signalling: the role of insulin receptor substrate 1
Keller, S. R., & Lienhard, G. E. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90065-5 · Cited by 79
Lipoproteins Containing Apo B Extracted from Human Aortas Structure and Functiona
Hoff, H. F., & Morton, R. E. (1985) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1985.tb11857.x · Cited by 79
Davis, C. N., Tabarean, I. V., Gaidarova, S., Behrens, M. M., & Bartfai, T. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03951.x · Cited by 78
Involvement of novel PKC isoforms in FFA induced defects in insulin signaling
Dey, D., Basu, D., Roy, S. S., Bandyopadhyay, A., & Bhattacharya, S. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.12.014 · Cited by 77
Regulation of de novo sphingolipid biosynthesis and the toxic consequences of its disruption
Linn, S. C., Kim, H. S., Keane, E. M., Andras, L. M., Wang, E., & Merrill, A. H. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290831 · Cited by 77
Santana, M., Llanes, L., Hernández, I., et al. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641202 · Cited by 76
Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY7201
Wijkstrom, M. N., Kenyon, N. S., Kirchhof, N., Kenyon, N. M., Mullon, C. J. P., Lake, P., Cottens, S., Ricordi, C., & Hering, B. J. (2004) · Transplantation · doi:10.1097/01.tp.0000116390.76425.20 · Cited by 74
Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
Gillard, B. K., Thomas, J. W., Nell, L. J., & Marcus, D. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.11.3826 · Cited by 73
Sabin, M. A., Stewart, C. E. H., Crowne, E. C., Turner, S. J., Hunt, L. P., Welsh, G. I., Grohmann, M. J., Holly, J. M. P., & Shield, J. P. H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20922 · Cited by 71
Synthesis and Biological Activity of a Novel Inhibitor of Dihydroceramide Desaturase
Munoz-Olaya, J. M., Matabosch, X., Bedia, C., Egido‐Gabás, M., Casas, J., Llebaria, A., Delgado, A., & Fabriàs, G. (2008) · ChemMedChem · doi:10.1002/cmdc.200700325 · Cited by 70
Glaros, E. N., Kim, W. S., Wu, B. J., Suarna, C., Quinn, C. M., Rye, K., Stocker, R., Jessup, W., & Garner, B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.023 · Cited by 70
Maki, T., Gottschalk, R., Ogawa, N., & Monaco, A. P. (2005) · Transplantation · doi:10.1097/01.tp.0000161220.87548.ee · Cited by 68
Saad, M. J. A., Folli, F. B., Araki, E., Hashimoto, N., Csermely, P., & Kahn, C. R. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.5.7520127 · Cited by 67
Liu, L., Zhao, H., Zuo, J., Ho, S. K. S., Chan, J. C. N., Meng, Y., Fang, F., & Tong, P. C. Y. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-10-0969 · Cited by 61
Nutrition, Lipids, and Cardiovascular Disease
Kuller, L. H. (2006) · Nutrition Reviews · doi:10.1111/j.1753-4887.2006.tb00230.x · Cited by 61
Tumor necrosis factor alpha signaling pathway and apoptosis in pancreatic β cells
Ishizuka, N., Yagui, K., Tokuyama, Y., Yamada, K., Suzuki, Y., Miyazaki, J., Hashimoto, N., Makino, H., Saitō, Y., & Kanatsuka, A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90234-2 · Cited by 59
The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice☆
Yang, Z., Chen, M., Fialkow, L. B., Ellett, J. D., Wu, R., Brinkmann, V., Nadler, J. L., & Lynch, K. R. (2003) · Clinical Immunology · doi:10.1016/s1521-6616(02)00054-2 · Cited by 59
Todd, M. K., Watt, M. J., Le, J., Hevener, A. L., & Turcotte, L. P. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00080.2006 · Cited by 59
Ceramide‐activated protein phosphatase‐2A activity in insulin‐secreting cells
Kowluru, A., & Metz, S. A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01379-3 · Cited by 54
An, D., Kewalramani, G., Chan, J. K. Y., Qi, D., Ghosh, S., Pulinilkunnil, T., Abrahani, A., Innis, S. M., & Rodrigues, B. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0338-9 · Cited by 54
Ramachandran, C. K., Murray, D. K., & Nelson, D. H. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92068-b · Cited by 51
Pillutla, P., Hwang, Y. C., Augustus, A. S., Yokoyama, M., Yagyu, H., Johnston, T. P., Kaneko, M., Ramasamy, R., & Goldberg, I. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00273.2004 · Cited by 51
Saad, M. J. A., Folli, F. B., & Kahn, C. R. (1995) · Endocrinology · doi:10.1210/en.136.4.1579 · Cited by 50
Fu, F., Hu, S., DeLeo, J., Li, S., Hopf, C. E., Hoover, J. L., Wang, S., Brinkmann, V., Lake, P., & Shi, V. C. (2002) · Transplantation · doi:10.1097/00007890-200205150-00011 · Cited by 49
Leptin, skeletal muscle lipids, and lipid-induced insulin resistance
Dubé, J. J., Bhatt, B. A., Dedousis, N., Bonen, A., & O'Doherty, R. M. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2007 · Cited by 49
The effect of dietary sphingolipids on plasma sphingomyelin metabolism and atherosclerosis
Li, Z., Basterr, M. J., Hailemariam, T. K., Hojjati, M. R., Lu, S., Liu, J., Liu, R., Zhou, H., & Jiang, X.-C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.05.004 · Cited by 46
Johnston, D., Matthews, E. R., & Melnykovych, G. (1980) · Endocrinology · doi:10.1210/endo-107-5-1482 · Cited by 45
Alterations in growth and apoptosis of insulin receptor substrate-1-deficient β-cells
Hennige, A. M., Özcan, U., Okada, T., Jhala, U. S., Schubert, M., White, M. F., & Kulkarni, R. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2004 · Cited by 45
Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin
Memon, R. A., Holleran, W. M., Uchida, Y., Moser, A. H., Grünfeld, C., & Feingold, K. R. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31670-9 · Cited by 44
Plomgaard, P., Keller, P., Keller, C., & Pedersen, B. K. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01220.2004 · Cited by 44
Insulin Resistance as a Membrane Microdomain Disorder
Inokuchi, J. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1532 · Cited by 43
Meyer, S. G. E., & de GROOT, H. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.10.002 · Cited by 42
Xing, L., & Quinn, P. G. (1993) · Molecular Endocrinology · doi:10.1210/mend.7.11.8114762 · Cited by 42
Morita, S., Okuhira, K., Tsuchimoto, N., Vertut‐Doï, A., Saito, H., Nakano, M., & Handa, T. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00365-7 · Cited by 42
Górska, M., Dobrzyń, A., Żendzian‐Piotrowska, M., & Górski, J. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814197 · Cited by 37
Murray, D. K., Ruhmann‐Wennhold, A., & Nelson, D. H. (1979) · Endocrinology · doi:10.1210/endo-105-3-774 · Cited by 36
The Sphingomyelin‐Signaling Pathway in Skeletal Muscles and Its Role in Regulation of Glucose Uptake
Górski, J., Dobrzyń, A., & Żendzian‐Piotrowska, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04279.x · Cited by 34
Kotani, K., Ogawa, W., Hashiramoto, M., Onishi, T., Ohno, S., & Kasuga, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002537200 · Cited by 33
Planavila, A., Alegret, M., Sánchez, R. M., Rodríguez‐Calvo, R., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.01.015 · Cited by 32
Dobrzyń, A., & Górski, J. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-34793 · Cited by 31
Bai, Y., Wang, J., Shan, H., Lu, Y., Zhang, Y., Luo, X., Yang, B., & Wang, Z. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000107527 · Cited by 31
Csehi, S.-B., Mathieu, S., Seifert, U., Lange, A., Zweyer, M., Wernig, A., & Adam, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.01.140 · Cited by 28
Pioglitazone induces de novo ceramide synthesis in the rat heart
Baranowski, M., Błachnio-Zabielska, A. U., Zabielski, P., & Górski, J. (2006) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2006.10.004 · Cited by 27
Soeda, S., Honda, O., Shimeno, H., et al. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00206-5 · Cited by 27
Cazzolli, R., Mitchell, T. W., Burchfield, J. G., Pedersen, D. J., Turner, N. A., Biden, T. J., & Schmitz‐Peiffer, C. (2007) · Diabetologia · doi:10.1007/s00125-007-0709-x · Cited by 25
Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles.
Zendzian-Piotrowska, M., Baranowski, M., Zabielski, P., & Górski, J. (2006) · PubMed · Cited by 25
Serlie, M. J. M., Allick, G., Groener, J. E. M., Ackermans, M. T., Heijligenberg, R., Voermans, B. C., Aerts, J. M. F. G., Meijer, A. J., & Sauerwein, H. P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1518 · Cited by 24
Protein kinase Cζ and glucose uptake
Liu, L., He, A., Liu, X., Li, Y., Chang, Y., & Fang, F. (2006) · Biochemistry (Moscow) · doi:10.1134/s0006297906070017 · Cited by 22
Pileggi, A., Fenjves, E. S., Klein, D., Ricordi, C., & Pastori, R. L. (2004) · IUBMB Life · doi:10.1080/15216540400006469 · Cited by 22
Effect of acute exercise and training on metabolism of ceramide in the heart muscle of the rat
Dobrzyń, A., Knapp, M., & Górski, J. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01295.x · Cited by 22
Free Fatty Acid-Induced Insulin Resistance in the Obese Is Not Prevented by Rosiglitazone Treatment
Dhindsa, S., Tripathy, D., Sanalkumar, N., Ravishankar, S. T., Ghanim, H., Aljada, A., & Dandona, P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0223 · Cited by 22
Popovic, J., Kover, K. L., & Moore, W. V. (2004) · Pediatric Diabetes · doi:10.1111/j.1399-543x.2004.00036.x · Cited by 21
Georg, B., Helseth, E., Lund, L. R., Skandsen, T., Riccio, A., Dane, K., Unsgaard, G., & Andreasen, P. A. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90192-5 · Cited by 21
Long‐term effect of FTY720 on lymphocyte count and islet allograft survival in mice
Liu, L., Wang, C., He, X., Shang, W., Bi, Y., & Wang, D. (2007) · Microsurgery · doi:10.1002/micr.20360 · Cited by 17
Adrenalectomy Decreases the Sphingomyelin and Cholesterol Content of Fat Cell Ghosts*
Murray, D. K., Ruhmann‐Wennhold, A., & Nelson, D. H. (1982) · Endocrinology · doi:10.1210/endo-111-2-452 · Cited by 9
Senn, J. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.a109.513304 · Cited by 8
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Incalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Metabolic Flexibility in Health and Disease
Goodpaster, B. H., & Sparks, L. M. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.015 · Cited by 995
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892
Self-citation
Metadata
- Authors
- Holland, W. L., & Summers, S. A.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05-01
- Volume
- 29
- Issue
- 4
- Pages
- 381-402
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2164509237
- Cited by
- 595
- References
- 276
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.